Hundreds of people living in Bristol are at risk of having their vision ‘stolen’ by a condition often dubbed as the ‘silent ...

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread ... and Economic Review (ICER) poked holes in the design of the clinical studies ...

Biotech company Neurotech Pharmaceuticals this month received regulatory approval for its treatment of a a neurodegenerative ...

A surgical procedure to restore the power of sight to blind patients using their teeth is slowly gaining traction around the ...

Researchers combined advanced imaging techniques and theoretical physics to observe and explain how nanoclusters of the protein emerin form inside living cells. The study uncovers the molecular 'rules ...

That suggests doctors may be able to use data from the devices to help ... Jan. 14, 2025 — Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result ...

Breaks may be subdivided into tears, holes, and dialyses ... and retinopathy of prematurity. A macular pucker should be thought of as a small, localized traction RD. Exudative (serous) RD occurs ...

Most people tolerate the treatment well, but some experience bruising ... a healthcare provider uses the tip of a needle to poke tiny holes in the tight cord beneath the skin.

The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD), sending its shares soaring and prompting a $150 million offering to ...

Trusted, comprehensive information to help you get on the path to clear skin.